Cargando…
Pharmacists expanded role in providing care for opioid use disorder during COVID-19: A qualitative study exploring pharmacists’ experiences
INTRODUCTION: During the COVID-19 pandemic, patients with opioid use disorder (OUD) struggled with access to prescribers and opioid agonist therapy (OAT). Recognizing this gap in care, Health Canada issued a short-term subsection 56(1) class exemption from the Controlled Drugs and Substances Act aut...
Autores principales: | Bishop, Lisa D., Rosenberg-Yunger, Zahava R.S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743855/ https://www.ncbi.nlm.nih.gov/pubmed/35032858 http://dx.doi.org/10.1016/j.drugalcdep.2022.109303 |
Ejemplares similares
-
Pharmacists’ perceptions of the Canadian opioid regulatory exemptions on patient care and opioid stewardship
por: Bishop, Lisa D., et al.
Publicado: (2021) -
Uptake of Travel Health Services by Community Pharmacies and Patients Following Pharmacist Immunization Scope Expansion in Ontario, Canada
por: Houle, Sherilyn K. D., et al.
Publicado: (2019) -
U.S. student pharmacist perceptions of the pharmacist’s role in
methadone for opioid use disorder: A qualitative study
por: Hohmeier, Kenneth C, et al.
Publicado: (2021) -
The Expanding Role of the Oncology Pharmacist
por: Holle, Lisa M., et al.
Publicado: (2020) -
Experience of Patients with COPD of Pharmacists’ Provided Care: A Qualitative Study
por: Idowu, Omowumi, et al.
Publicado: (2021)